Published in Healthcare Mergers, Acquisitions and Ventures Week, May 5th, 2007
Traditionally, high-throughput laboratories experience a bottleneck in the interpretation of NMR spectra as the ability to generate more data increases. The combined system from ACD/Labs and Protasis allows users to seamlessly collect samples, and automatically confirm the identity of the synthesized compounds in a matter of minutes. One particular laboratory within a large pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.